Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India flag India · Delayed Price · Currency is INR
923.45
+35.30 (3.97%)
At close: Feb 9, 2026

Zydus Lifesciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
929,207891,9261,013,630497,549356,774451,368
Market Cap Growth
-7.24%-12.01%103.72%39.46%-20.96%64.98%
Enterprise Value
982,762892,1811,022,435525,557387,118504,363
Last Close Price
923.45876.36993.46480.30338.10425.24
PE Ratio
18.8919.7126.2625.387.9521.16
Forward PE
21.8119.0128.4621.3916.5726.84
PS Ratio
3.793.845.192.892.363.13
PB Ratio
3.313.384.592.531.873.02
P/TBV Ratio
9.955.768.484.283.407.04
P/FCF Ratio
36.6117.6144.2730.0139.5618.50
P/OCF Ratio
22.4213.1631.7118.5016.9513.70
PEG Ratio
7.922.151.531.793.031.51
EV/Sales Ratio
4.013.845.233.052.563.50
EV/EBITDA Ratio
14.0213.0619.4514.8712.2114.77
EV/EBIT Ratio
16.2914.9722.5318.4215.6518.44
EV/FCF Ratio
38.7217.6244.6531.7042.9220.67
Debt / Equity Ratio
0.340.120.040.060.220.31
Debt / EBITDA Ratio
1.320.470.160.341.331.35
Debt / FCF Ratio
-0.640.360.724.681.89
Asset Turnover
-0.700.710.640.590.61
Inventory Turnover
-1.771.871.811.641.64
Quick Ratio
-1.121.301.050.960.57
Current Ratio
-1.892.141.811.541.11
Return on Equity (ROE)
-19.28%18.90%10.82%13.96%16.91%
Return on Assets (ROA)
-11.21%10.31%6.66%5.98%7.19%
Return on Invested Capital (ROIC)
15.34%20.11%17.64%11.43%10.78%13.64%
Return on Capital Employed (ROCE)
-21.20%19.00%14.10%12.40%17.10%
Earnings Yield
5.29%5.07%3.81%3.94%12.58%4.73%
FCF Yield
2.73%5.68%2.26%3.33%2.53%5.41%
Dividend Yield
1.24%1.26%0.30%1.25%0.74%0.82%
Payout Ratio
22.47%6.68%16.09%13.63%8.29%0.07%
Buyback Yield / Dilution
0.27%0.56%0.37%0.79%--
Total Shareholder Return
1.51%1.82%0.67%2.04%0.74%0.82%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.